Bank of America’s Insys Therapeutics, Inc. INSY Stock Holding History

Bank of America’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-100,500	Closed	-$925K	–	7413
2016 Q4	$925K	Buy	+100,500	New	+$1.14M	﹤0.01%	4402
2016 Q2	–	Sell	-25,000	Closed	-$400K	–	7553
2016 Q1	$400K	Buy	25,000 +15,000	+150%	+$285K	﹤0.01%	4733
2015 Q4	$286K	Hold	10,000	–	–	﹤0.01%	5150
2015 Q3	$285K	Buy	+10,000	New	+$368K	﹤0.01%	5146

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Bank of America's INSY Position: Q2 2019 in Review

Bank of America sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 31,257 shares — an estimated $144K sold.

Bank of America first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $4.93M in Q4 2013. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Bank of America reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Bank of America sold 31,257 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $144K.
Bank of America first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
Bank of America's Insys Therapeutics, Inc. position peaked at $4.93M in Q4 2013.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Bank of America's 13F filing for Q2 2019, filed 14 Aug 2019.